WINDRIDGE CONSTRUCTION INCBusiness Directories,Company Directories

Company Name: Corporate Name:	WINDRIDGE CONSTRUCTION INC
Company Title:
Company Description:
Keywords to Search:
Company Address:	4166 Mount Albert Rd,SHARON,ON,Canada
ZIP Code: Postal Code:	L0G1V0
Telephone Number:	9054733229
Fax Number:
Website:
Email:
USA SIC Code(Standard Industrial Classification Code):	154213
USA SIC Description:	Building Contractors
Number of Employees:	1 to 4
Sales Amount:	$1 to 2.5 million
Credit History: Credit Report:	Good
Contact Person:	Maria Antonacci
Remove my name

Company Directories & Business Directories

copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)

Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Previous company profile:
AMR STRETCH LIMOUSINE
YORK REGION DISTRICT SCHOOL BOARD
YORK CATHOLIC DISTRICT SCHOOL BOARD

Next company profile:
WIEDEMANNS SERVICE CTR & GAS
VINCES COUNTRY MARKET
TRICO ENERGY SERVICES LTD

Company News:

OPDIVO U. S. Prescribing Information - BMS
OPDIVO® (nivolumab) injection, for intravenous use Initial U S Approval: 2014-----RECENT MAJOR CHANGES-----Indications and Usage (1) 5 2025 Dosage and Administration (2) 5 2025
Food and Drug Administration
Food and Drug Administration
OPDIVO® (nivolumab)
OPDIVO ® (nivolumab) is a prescription medicine used in combination with YERVOY ® (ipilimumab) and 2 cycles of chemotherapy that contains platinum and another chemotherapy medicine, as a first treatment for adults with a type of advanced stage lung cancer (called non-small cell lung cancer) when your lung cancer has spread or grown, or comes bac
OPDIVO- nivolumab injection - DailyMed
See How Supplied section for a complete list of available packages of OPDIVO NDC 0003-3772-11 - Rx only - Opdivo® (nivolumab) injection - 40 mg 4 mL - (10 mg mL) For intravenous Infusion
Opdivo: Package Insert Prescribing Information - Drugs. com
Opdivo package insert prescribing information for healthcare professionals Includes: indications, dosage, adverse reactions and pharmacology
Adverse Reaction Severity Dose Modi˜cation Nivolumab INN
Nivolumab is a human immunoglobulin G4 (IgG4) monoclonal antibody that binds to the PD-1 receptor and blocks its interaction with PD-L1 and PD-L2, releasing PD-1 pathway-mediated inhibition of the immune response, including the anti-tumor immune response In syngeneic mouse tumor models, blocking PD-1 activity resulted in decreased tumor growth
Dosing Information | OPDIVO® (nivolumab)
Find instructions for preparation, administration, and storage for both OPDIVO infusions and OPDIVO Qvantig subcutaneous injections Go to Info A guide to dosing intravenous OPDIVO and subcutaneous injection OPDIVO Qvantig Download ⤓ OPDIVO Qvantig [package insert] Princeton, NJ: Bristol-Myers Squibb Company OPDIVO [package insert]
OPDIVO (nivolumab) injection Label - Food and Drug Administration
OPDIVO (nivolumab) is indicated for the treatment of patients with unresectable or metastatic melanoma and disease progression following ipilimumab and, if BRAF V600 mutation positive, a BRAF
OPDIVO QVANTIG U. S. Prescribing Information
OPDIVO QVANTIG is a combination of nivolumab, a programmed death receptor-1 (PD-1)-blocking antibody, and hyaluronidase, an endoglycosidase, indicated for the treatment of: Renal Cell Carcinoma (RCC) • adult patients with intermediate or poor risk advanced RCC, as a first-line treatment
Nivolumab - Amazon Web Services
Package insert: Nivolumab Intravenous Cancer Treatment Education (Explore the treatment regimens associated with this drug by searching